NCR3LG1 and melanoma: The NKp30 ligand B7-H6 was reported to be shed by tumor cells through metalloprotease-mediated cleavage, and high levels of soluble B7-H6 were found in the serum of patients with melanoma, suggesting a B7-H6-decoy mechanism of immune evasion [68].